Publications by authors named "Anna Festi"
Objectives: To report the first cases of surgical staging for apparently early-stage endometrial cancer performed using the Versius® next-generation robotic surgical system (Cambridge Medical Robots [CMR] Surgical, Cambridge, UK).
Design: Prospective case series. Participants/Materials: Women who underwent surgical staging, including total hysterectomy, bilateral adnexectomy, and sentinel lymph node (SLN) biopsy, for apparently early-stage endometrial cancer using the Versius® next-generation robotic surgical system (CMR Surgical, Cambridge, UK).
Article Synopsis
- Oncovascular surgery, which involves removing major blood vessels affected by cancer, is crucial for achieving complete removal of tumors in advanced ovarian cancer patients.
- A review of patient cases at Verona University showed that five patients had successful major vascular resections, with all having preoperative identification of vascular involvement and obtaining R0 status (no visible cancer remaining).
- The literature review found a total of 12 cases of major vessel resections in ovarian cancer, with a notable percentage experiencing postoperative complications, yet a majority remained disease-free at their last follow-up.
Objective: This study aimed to assess the effects on oncologic outcomes of intrauterine manipulator use during laparoscopic hysterectomy for endometrial cancer.
Data Sources: A systematic literature search was performed by an expert librarian in multiple electronic databases from inception to January 31, 2023.
Study Eligibility Criteria: We included all studies in the English language that compared oncologic outcomes (recurrence-free, cause-specific, or overall survival) between endometrial cancer patients who underwent total laparoscopic or robotic hysterectomy for endometrial cancer with vs without the use of an intrauterine manipulator.
Objectives: To evaluate oncological and reproductive outcomes of women undergoing fertility-sparing surgery (FSS) for stage II-III serous borderline ovarian tumors (BOTs).
Methods: A multi-institutional retrospective study was conducted within the MITO Group.
Results: A total of 91 patients were recruited.